Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective

Marta Cano-Megías1, Pablo Guisado-Vasco2, Hanane Bouarich3

  • 1'Principe de Asturias' University Hospital, Ctra Alcalá-Meco s/n. Alcalá de Henares, 28805, Madrid, Spain. mcanomegias@gmail.com.

BMC Nephrology
|May 30, 2019
PubMed

Insights

Severe coronary artery calcification (CaC) significantly increases cardiovascular mortality in advanced chronic kidney disease (CKD) patients over 10 years. CaC is a valuable tool for predicting cardiovascular mortality risk in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Patients with advanced chronic kidney disease (CKD) have a higher prevalence of coronary artery calcification (CaC).
  • CaC is a potential mortality risk factor in end-stage CKD, but previous studies had short follow-up periods.

Purpose of the Study:

  • To investigate the long-term association between CaC and mortality in advanced CKD patients.
  • To assess CaC as a prognostic tool for cardiovascular (CV) mortality risk in this population.

Main Methods:

  • A 10-year prospective longitudinal cohort study of 137 advanced CKD patients.
  • Coronary computed tomography (CT) was used to assess CaC at baseline, stratified into severe (≥400 HU) and mild-moderate (<400 HU) groups.
  • Overall and CV mortality, CV events, and associated factors were recorded.

Main Results:

  • Overall mortality was 58%, with 40% due to CV events.
  • The severe CaC group had significantly higher overall (75% vs. 30%) and CV mortality (35% vs. 6%) compared to the mild-moderate group (p < 0.001).
  • Severe CaC independently predicted CV mortality (HR 5.01; p=0.02) and was associated with older age, diabetes, prior CV events, and lower albumin.

Conclusions:

  • Severe CaC is associated with significantly increased CV mortality in advanced CKD patients over a 10-year follow-up.
  • Coronary artery calcification scoring can serve as a prognostic indicator for cardiovascular mortality risk in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
612
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
373
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
338
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
434
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934